These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27638330)

  • 21. [Thalidomide embryopathy 60 years].
    Passarge E
    Dtsch Med Wochenschr; 2022 Dec; 147(24-25):1635-1638. PubMed ID: 36470274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalidomide Embryopathy as Possible Cause of Anterior Sacral Meningocele: A Case Report.
    Croci DM; Dalolio M; Schaeren S; Wasner MG; Mariani L; Jost GF
    Birth Defects Res; 2017 Oct; 109(17):1390-1392. PubMed ID: 28990356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic susceptibility to thalidomide embryopathy in humans: Study of candidate development genes.
    Gomes JDA; Kowalski TW; Fraga LR; Tovo-Rodrigues L; Sanseverino MTV; Schuler-Faccini L; Vianna FSL
    Birth Defects Res; 2018 Mar; 110(5):456-461. PubMed ID: 29193903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a Pregnancy Prevention Programme (PPP) with a Controlled Distribution System (CDS) for the Generic Teratogenic Phthalimides Thalidomide, Lenalidomide and Pomalidomide.
    Mueller M; Lewis DJ
    Ther Innov Regul Sci; 2021 Nov; 55(6):1155-1164. PubMed ID: 34331266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide Teratogenic Effects Linked to Degradation of SALL4: After 60 years, researchers have now shed light on the mechanism underlying thalidomide's devastating teratogenic effects.
    Am J Med Genet A; 2018 Dec; 176(12):2538-2539. PubMed ID: 30597765
    [No Abstract]   [Full Text] [Related]  

  • 26. Thalidomide revisited.
    Cutler J
    Lancet; 1994 Mar; 343(8900):795-6. PubMed ID: 7907755
    [No Abstract]   [Full Text] [Related]  

  • 27. Refractive evaluation in thalidomide embryopathy.
    Strömland K; Miller MT
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):140-9. PubMed ID: 1577294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thalidomide in Brazil: monitoring with shared responsibility?].
    Oliveira MA; Bermudez JA; Souza AC
    Cad Saude Publica; 1999; 15(1):99-112. PubMed ID: 10203451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratogen update: clinical aspects of thalidomide embryopathy--a continuing preoccupation.
    Newman CG
    Teratology; 1985 Aug; 32(1):133-44. PubMed ID: 4035587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Offspring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies.
    Strömland K; Philipson E; Andersson Grönlund M
    Teratology; 2002 Sep; 66(3):115-21. PubMed ID: 12210472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.
    Knobloch J; Jungck D; Koch A
    Curr Mol Med; 2017; 17(2):108-117. PubMed ID: 28429672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The thalidomide experience: review of its effects 50 years later].
    Martínez-Frías ML
    Med Clin (Barc); 2012 Jun; 139(1):25-32. PubMed ID: 22177324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratogenic effects of thalidomide: molecular mechanisms.
    Ito T; Ando H; Handa H
    Cell Mol Life Sci; 2011 May; 68(9):1569-79. PubMed ID: 21207098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?
    Kowalski TW; Dupont ÁV; Rengel BD; Sgarioni E; Gomes JDA; Fraga LR; Schuler-Faccini L; Vianna FSL
    Reprod Toxicol; 2019 Sep; 88():67-75. PubMed ID: 31362043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
    Lee CJ; Gonçalves LL; Wells PG
    Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
    Parman T; Wiley MJ; Wells PG
    Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical review and introduction of the diagnostic algorithm for thalidomide embryopathy (DATE).
    Mansour S; Baple E; Hall CM
    J Hand Surg Eur Vol; 2019 Jan; 44(1):96-108. PubMed ID: 30253685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rehabilitation of thalidomide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the molecular mechanism of thalidomide teratogenicity.
    Gao S; Wang S; Fan R; Hu J
    Biomed Pharmacother; 2020 Jul; 127():110114. PubMed ID: 32304852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic evaluation of HAND2 gene and its effects on thalidomide embryopathy.
    Rengel BD; Kowalski TW; Bremm JM; do Amaral Gomes J; Schüler-Faccini L; Vianna FSL; Fraga LR
    Birth Defects Res; 2022 Dec; 114(20):1354-1363. PubMed ID: 36177858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.